NextCell Pharma AB Financial Overview
NextCell Pharma AB's market cap is currently €8.70M. The company's EPS TTM is €-0.0072206; its P/E ratio is -1.55; NextCell Pharma AB is scheduled to report earnings on October 30, 2025, and the estimated EPS forecast is €―. See an overview of income statement, balance sheet, and cash flow financials.
